RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
Over 1/2 of residents in 6 Australian residential aged care services prescribed a PPI, with 23% prescribed a high dose - only half had documented clinical indication or on meds that increase risk of bleeding - opportunity for #deprescribing in #RMMRs https
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
RT @JanetSluggett: Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review i…
Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services https://t.co/8GTVRAXRJo
Our new research shows 1 in 2 residents receive proton pump inhibitors (PPIs) regularly: opportunities exist to review if indications are still current, step-down therapy and #deprescribe PPIs in #residentialagedcare. Full paper here: https://t.co/bOR5oNol